An S-nitrosylated hemoglobin derivative protects the rat hippocampus from ischemia-induced long-term potentiation impairment with a time window.

An S-nitrosylated hemoglobin derivative protects the rat hippocampus from ischemia-induced long-term potentiation impairment with a time window.
复制标题

DOI:
10.1254/jphs.fp0040385
复制
发表时间:
2004
影响因子:
3.5
通讯作者:
H. Otani;S. Jesmin;H. Togashi;I. Sakuma;K. Nakai;H. Satoh;M. Yoshioka;A. Kitabatake
H. Otani;S. Jesmin;H. Togashi;I. Sakuma;K. Nakai;H. Satoh;M. Yoshioka;A. Kitabatake
中科院分区:
医学3区
文献类型:
--
作者:
H. Otani;S. Jesmin;H. Togashi;I. Sakuma;K. Nakai;H. Satoh;M. Yoshioka;A. Kitabatake

文献摘要

相似文献

有证据表明,s -亚硝基化是参与脑缺血的一个生物学过程。本研究的目的是阐明s -亚硝基化(SNO)聚乙二醇共轭(PEG)血红蛋白(Hb)作为一种人工氧载体,可以吸收游离NO并将NO转运到巯基(SH)部分,对缺血性脑功能障碍的影响。大鼠海马穿孔通路-齿状回突触的长期增强(LTP)作为短暂性脑缺血(2血管闭塞:2VO, 10 min)后4天的功能结果进行评估。SNO-PEG-Hb (250 mg/kg,静脉注射)在第0、1、2或4天(分别在再灌注后立即、24小时、48小时或96小时)减轻了2vo诱导的LTP损伤。当第1天或第2天给予SNO-PEG-Hb时,效果显著。SNO-PEG-Hb改变了2VO大鼠的NOS特征,在mRNA和蛋白水平上上调eNOS、nNOS和iNOS的表达;SNO-PEG-Hb进一步上调eNOS和nNOS表达,下调iNOS表达。这些发现提示SNO-PEG-Hb可能对大鼠海马缺血/再灌注引起的功能损伤具有保护作用,从而增加了作为人工氧载体在氧疗领域的应用潜力。
Evidence suggests that S-nitrosylation is a biological process involved in cerebral ischemia. The aim of the present study was to elucidate the effects of S-nitrosylated (SNO) polyethylene glycol-conjugated (PEG) hemoglobin (Hb) developed as an artificial oxygen carrier, which can absorb free NO and translocate NO to a sulfhydryl (SH) moiety, on ischemic cerebral dysfunction. Long-term potentiation (LTP) in the perforant path-dentate gyrus synapses of the rat hippocampus was evaluated as functional outcome 4 days after transient incomplete cerebral ischemia (2-vessel occlusion: 2VO, 10 min). SNO-PEG-Hb (250 mg/kg, i.v.) administered on Day 0, 1, 2, or 4 (immediately, 24 h, 48 h, or 96 h after reperfusion, respectively) alleviated 2VO-induced LTP impairment with a therapeutic time window. The effect was significant when SNO-PEG-Hb was administered on Day 1 or 2. SNO-PEG-Hb altered NOS features observed in the vehicle-treated 2VO rat, upregulation of eNOS, nNOS, and iNOS expressions at mRNA and protein levels; SNO-PEG-Hb further upregulated eNOS and nNOS and downregulated iNOS expressions. These findings suggest that SNO-PEG-Hb might have protective effects on the rat hippocampus from ischemia/reperfusion-induced functional damages, thereby increasing the therapeutic potential as an artificial oxygen carrier for use in the area of oxygen therapy.